Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail
The DNA-sequencing company said the activist investor hasn’t offered any better solutions for satisfying regulators’ concerns about the acquisition.
Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail Read More »
